Table 2 Neutralization potencies of the selected antibodies obtained against the SARS-CoV-2 virus.
Clone | Live SARS-CoV-2 virus IC50 (ng/mL) |
---|---|
#41 | 3.4 |
A12 | 1.3 |
B3 | 5.6 |
D2 | 34.8 |
D3 | 1.8 |
F1 | 1.7 |
F7 | 3.5 |
G2 | 3.3 |
G5 | 12.1 |
G12 | 1.7 |
Clone | Live SARS-CoV-2 virus IC50 (ng/mL) |
---|---|
#41 | 3.4 |
A12 | 1.3 |
B3 | 5.6 |
D2 | 34.8 |
D3 | 1.8 |
F1 | 1.7 |
F7 | 3.5 |
G2 | 3.3 |
G5 | 12.1 |
G12 | 1.7 |